CAMBRIDGE, Mass.-- (BUSINESS WIRE)--BIND Therapeutics, Inc. (NASDAQ:BIND), a clinical-stage nanomedicine company developing targeted and programmable therapeutics called ACCURINS®, today announced ...

Responding to the needs of construction professionals for reliable, user-friendly tools, RPX Technologies introduced the InSite Cellular Remote, a solution designed to make concrete monitoring simpler ...